<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="88914">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01743352</url>
  </required_header>
  <id_info>
    <org_study_id>2012-01</org_study_id>
    <secondary_id>ID - RCB 2012-A01255-38</secondary_id>
    <nct_id>NCT01743352</nct_id>
  </id_info>
  <brief_title>Comparison of Ultrafast Echo With Echotracking</brief_title>
  <official_title>Protocole ULTRAFAST - ECHOTRACKING : Remodelage pariétal et rigidité artérielle Chez l'Hypertendu : Nouvelle étude de Leur Relation Utilisant l'élastographie Par Ultrafast-écho et la séparation Intima/média Par écho-tracking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to compare a new technique for assessing mechanical properties of large arteries:
      the Ultrafast echo with the reference technique, the echotracking. This will be done by
      studying in parallel hypertensive patients and controls with both techniques and this will
      revisit old concepts of increased stiffness in hypertensive arteries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ultrafast ECHO is a new non invasive method for assessing stiffness of living tissues. It
      takes advantage of very fast imaging technologies (up to 20 000 images/sec) to measure the
      diffusion of pressure waves in the tissues. This pressure wave can be either natural (blood
      pressure), or generated by an very short ultrasonic impulsion at a given place. By using
      both modes, it is possible to have a precise cartography of tissue mechanical properties.
      This technique is applied to solid tissues such as breast or liver, but not yet currently to
      hollow tissues such as arteries. The aim of the present study is to compare the values of
      stiffness obtained with Ultrafast ECHO with the reference non invasive technique, the
      Echotracking, which measures stiffness by assessing the deformation of arteries in response
      to changes in blood pressure. On the physiological part, we will revisit old concepts of
      increased stiffness of hypertensive's arteries. Indeed, hypertension is associated with
      increased stiffness due to recruitement of collagen fibers, but also to chronic remodelling.
      We have shown before that this remodelling conducts to accumulation of arterial tissue of
      lesser intrinsic stiffness. The latter finding was done through models based on echotracking
      measurements. It will be interesting to see whether it holds true when stiffness is directly
      measured.

      Sixty subjects (30 normotensive and30 hypertensives) will be included and studied once.
      Measurement will be performed in random order 3 time on the common carotid artery on both
      sides. Aortic stiffness will be measured by pulse wave velocity
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Local common carotid artery pulse wave velocity</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Common carotid artery Young's modulus (Stiffness of wall material)</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Essential Untreated Hypertension</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Hypertension patients</arm_group_label>
    <description>Local common carotid artery pulse wave velocity is compared in patients with hypertension and healthy volunteers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <description>Local common carotid artery pulse wave velocity is compared in hypertension patients and healthy volunteers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting Essential untreated hypertension Healthy Volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hypertension,

          -  essential (WHO workup),

          -  untreated (&gt; 28 days of treatment interruption,  &lt; 6 months of treatment) on
             insufficiently equilibrated (BP &gt; 140 and/or 90 mmHg)

        Exclusion Criteria:

          -  Any concomitant severe disease compromising patient's  participation or compliance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Laurent, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pharmacology Department - Hopital Européen Georges Pompidou - Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphane Laurent, MD, PhD</last_name>
    <phone>(33) 1 56 09 39 91</phone>
    <email>stephane.laurent@egp.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre Boutouyrie, MD, PhD</last_name>
    <phone>(33) 1 56 09 39 66</phone>
    <email>pierre.boutouyrie@egp.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Européen Georges Pompidou / Service de Pharmacologie</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Laurent, MD, PhD</last_name>
      <phone>+33 (1).56.09.39.91</phone>
      <email>stephane.laurent@egp.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre Boutouyrie, MD, PhD</last_name>
      <phone>33 1 56 09 39 66</phone>
      <email>pierre.boutouyrie@egp.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Stéphane Laurent, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Boutouyrie, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel Azizi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne Blanchard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Briet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélien Lorthioir, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>December 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Large arteries</keyword>
  <keyword>stiffness</keyword>
  <keyword>intima media thickness</keyword>
  <keyword>ultrasound imaging</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
